These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27734718)

  • 41. Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity.
    Christ O; Lucke K; Imren S; Leung K; Hamilton M; Eaves A; Smith C; Eaves C
    Haematologica; 2007 Sep; 92(9):1165-72. PubMed ID: 17666374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aldehyde dehydrogenase as an alternative to enumeration of total and viable CD34(+) cells in autologous hematopoietic progenitor cell transplantation.
    Veeraputhiran M; Katragadda L; Balamurugan A; Cottler-Fox M
    Cytotherapy; 2011 Nov; 13(10):1256-8. PubMed ID: 21905957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human articular chondrocytes with higher aldehyde dehydrogenase activity have stronger expression of COL2A1 and SOX9.
    Unguryte A; Bernotiene E; Bagdonas E; Garberyte S; Porvaneckas N; Jorgensen C
    Osteoarthritis Cartilage; 2016 May; 24(5):873-82. PubMed ID: 26687820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay.
    Shoulars K; Noldner P; Troy JD; Cheatham L; Parrish A; Page K; Gentry T; Balber AE; Kurtzberg J
    Blood; 2016 May; 127(19):2346-54. PubMed ID: 26968535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
    van Rhenen A; Moshaver B; Kelder A; Feller N; Nieuwint AW; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2007 Aug; 21(8):1700-7. PubMed ID: 17525725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In Vitro Identification and Characteristics of CD34
    Zhang YH; Yang L; Wang YZ; Kong Y; Zhu HH; Qin YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1289-1294. PubMed ID: 29070097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial frequency of CD34+/CD38 - cells is not correlated with minimal residual disease level in 73 Chinese children with B-cell precursor acute lymphoblastic leukemia.
    Feng JH; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Xu WQ
    Leuk Lymphoma; 2013 Sep; 54(9):2073-5. PubMed ID: 23323948
    [No Abstract]   [Full Text] [Related]  

  • 49. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
    Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
    Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia.
    Nakamura S; Tan L; Nagata Y; Takemura T; Asahina A; Yokota D; Yagyu T; Shibata K; Fujisawa S; Ohnishi K
    Mol Carcinog; 2013 Jan; 52(1):57-69. PubMed ID: 22086844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
    Prus E; Fibach E
    Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity.
    Povsic TJ; Zavodni KL; Kelly FL; Zhu S; Goldschmidt-Clermont PJ; Dong C; Peterson ED
    J Am Coll Cardiol; 2007 Dec; 50(23):2243-8. PubMed ID: 18061073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of STPK in Maintaining the Quiescent Nature of Human CD34
    Sunitha MM; Srikanth L; Kumar PS; Chandrasekhar C; Sarma PV
    J Stem Cells; 2016; 11(3):125-133. PubMed ID: 28296877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
    Ran D; Schubert M; Pietsch L; Taubert I; Wuchter P; Eckstein V; Bruckner T; Zoeller M; Ho AD
    Exp Hematol; 2009 Dec; 37(12):1423-34. PubMed ID: 19819294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance.
    Ran D; Schubert M; Taubert I; Eckstein V; Bellos F; Jauch A; Chen H; Bruckner T; Saffrich R; Wuchter P; Ho AD
    Exp Hematol; 2012 Feb; 40(2):155-65.e1. PubMed ID: 22024109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells.
    Quách TD; Hopkins TJ; Holodick NE; Vuyyuru R; Manser T; Bayer RL; Rothstein TL
    J Immunol; 2016 Nov; 197(10):3950-3958. PubMed ID: 27815443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.
    Matsuoka Y; Nakatsuka R; Sumide K; Kawamura H; Takahashi M; Fujioka T; Uemura Y; Asano H; Sasaki Y; Inoue M; Ogawa H; Takahashi T; Hino M; Sonoda Y
    Stem Cells; 2015 May; 33(5):1554-65. PubMed ID: 25537923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.